bictegravir + emtricitabine + tenofovir alafenamide Tablets 30 mg + 120 mg + 15 mg, 50 mg + 200 mg + 25 mg
Dossier type
US CTD
Dossier status
Under development
Country of origin
India
GMP approvals
FDA
Comments
Reference product: Biktarvy®
Manufacturer #15189
The company, which was founded in 1989, is involved in developing, manufacturing, and distributing a wide range of formulations for anti-infectives, cardiovascular, anti-diabetic, dermatological, and hormone treatment. The corporation has a global presence in 170 + countries, 60+ WHO-prequalified medications, and 3700+ product registrations.
Manufacturer usually replies in 29 days